PEOPLHE e RISP - Programmi di diagnosi precoce polmonare

  • Casa
  • Italia
  • Parma
  • PEOPLHE e RISP - Programmi di diagnosi precoce polmonare

PEOPLHE e RISP - Programmi di diagnosi precoce polmonare Il progetto Peoplhe ha l’obiettivo di diagnosticare il tumore polmonare in stadio precoce utilizzando la TAC a bassa dose.

Studio nazionale “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth (PEOPLHE)” promosso dall’Azienda Ospedaliero-Universitaria di Parma. PEOPLHE
Lo studio nazionale “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth (PEOPLHE)”, finanziato dal Ministero della Salute, è promosso dall’Azienda Ospedaliero-Universitaria di Parma e vede la partecipazione del Policlinico Vittorio Emanuele di Catania e del Policlinico San Matteo di Pavia. Gli esami diagnostici verranno eseguiti nell’Unità Operativa Scienze Radiologiche, diretta dal responsabile scientifico del progetto Nicola Sverzellati, mediante apparecchiatura di ultima generazione, che garantisce al paziente una minima esposizione alle radiazioni equipaggiata con sistemi avanzati di acquisizione delle immagini TC e di riduzione della dose radiante. Saranno 1.500 le persone inserite nello studio in tre anni, selezionate dai medici di medicina generale oppure dai professionisti dei 3 centri coinvolti (Parma, Catania e Pavia) in quanto soggetti ad elevato rischio di tumore polmonare. I requisiti per partecipare sono:
- età compresa fra 50 e 75 anni
- storia di tabagismo stimabile in almeno 10-15 si*****te al giorno per almeno 25-30 anni, inclusi ex fumatori da non oltre dieci anni
Lo studio prevede l’esecuzione di due TAC del torace a distanza di 2 anni. Se necessarie, saranno programmate anche delle TAC intermedie, da effettuarsi prima dei 2 anni, per l’eventuale controllo di noduli polmonari diagnosticati nel primo esame. I noduli polmonari rappresentano un riscontro frequente ma solo in una minima parte rappresentano un tumore (circa 1-3 diagnosi ogni 100 partecipanti). La diagnosi precoce permette la pianificazione di un trattamento curativo del tumore del polmone, prevalentemente tramite resezione chirurgica, anche con tecnica mini-invasiva. La resezione chirurgica riduce notevolmente la letalità del tumore polmonare, con un guadagno di circa il 25-40% a 10 anni. RISP
Diagnosi precoce del tumore del polmone nel contesto della “Rete Italiana Screening Polmonare” (Programma RISP): analisi comparativa di strategie di utilizzo della Tomografia Computerizzata a Basso Dosaggio (LDCT) e promozione di interventi di prevenzione primaria in soggetti ad alto rischio per la medesima patologia

ENTE FINANZIATORE: Ministero della Salute, Decreto legge 08/11/2021 “Individuazione dei centri che costituiscono la «Rete italiana screening polmonare» e dei criteri e delle modalità di riparto fra le regioni e le provincie autonome della spesa da destinare ai centri stessi.”

November is Lung Cancer Awareness Month 🫁To***co use remains one of the leading causes of preventable lung cancer. Quitt...
04/11/2025

November is Lung Cancer Awareness Month 🫁

To***co use remains one of the leading causes of preventable lung cancer. Quitting smoking isn't easy, but it leads to lasting benefits: better health, more energy, and a longer life.

The Project has created multilingual graphics to help raise awareness about why stopping smoking matters. Learn more about lung cancer prevention: https://europeanlung.org/solace/project-resources/



https://www.linkedin.com/showcase/solace-project/

Download a lung cancer screening recruitment flyer for each SOLACE centre, aimed specifically at women, produced by members of work package 4.

On  , Ilona's story is a powerful reminder: while fear of screening is natural, earlier detection of cancer can save liv...
10/10/2025

On , Ilona's story is a powerful reminder: while fear of screening is natural, earlier detection of cancer can save lives and mean a quicker return to normality.

As a partner in the Project , we advocate for lung cancer screening programmes that save lives and support mental wellbeing throughout the cancer care journey.

Link to SOLACE original post:

Today is World Day. Fear and stress because of a lung cancer diagnosis can be overwhelming, and it's one reason many people hesitate to get screened for lung cancer. But when lung cancer is detected early, before symptoms appear, treatment can be more effective and outcomes can be impr...

https://www.linkedin.com/feed/update/urn:li:activity:7378442571011862528
30/09/2025

https://www.linkedin.com/feed/update/urn:li:activity:7378442571011862528

🌍 Partner meeting at the ERS International Congress 2025! It was great to bring together consortium members today for the SOLACE project partner meeting. Collaborators from across Europe shared progress, aligned on next steps, and strengthened our joint mission to implement lung cancer screening ...

https://www.linkedin.com/feed/update/urn:li:activity:7378346834886336512
30/09/2025

https://www.linkedin.com/feed/update/urn:li:activity:7378346834886336512

🌍 News from the ERS International Congress 2025 The SOLACE Project is proud to be featured across multiple sessions, showcasing our progress in advancing lung cancer screening in Europe. 📅 Our sessions: ✅ 27 September – EU Projects Panel 👉 “European progress on finding SOLACE in lung ...

The  Project was part of the conversation at the recent  , with: 💬  Chorostowska-Wynimko and  Kerpel-Fronius introducing...
27/06/2025

The Project was part of the conversation at the recent , with:

💬 Chorostowska-Wynimko and Kerpel-Fronius introducing SOLACE’s goals and approach to integrating screening into national systems

💬 Palm discussing how AI tools can ease pressure on radiologists

💬 Prosch outlining SOLACE’s work on shared screening policies and training

💬 Beets-Tan placing the project within Europe’s wider cancer imaging strategy

💬 Mario Silva discussing how the ESTI position paper supports SOLACE’s focus on quality and standardisation

💬 Joanna Chorostowska-Wynimko and Hans-Ulrich Kauczor reflecting on SOLACE key achievements so far, including early pilot progress and stronger coordination

UNIPR is a proud partner in SOLACE, which is working to strengthen lung cancer screening across the EU.

Watch the interviews and learn more: https://shorturl.at/nzK4m

At the 2025 European Congress of Radiology (ECR), members of the SOLACE project team featured in a series of interviews highlighting its contribution to lung cancer screening across Europe, including:

📅 🌐 International Day of Radiology! “Today is the International Day of Radiology! It is a great day to raise awareness o...
08/11/2024

📅 🌐 International Day of Radiology!

“Today is the International Day of Radiology! It is a great day to raise awareness of the importance of low-dose CT lung cancer screening for Europe’s population at risk. It also allows us to celebrate the key role radiologists play in this multidisciplinary
team effort. It is great to see how the SOLACE project succeeds in setting up implementation pilots, developing science-based guidance for health professionals and decision-makers and in informing Europe’s citizens.”

Monika Hierath, EIBIR Executive Manager, ESR Director of European and International Affairs

SOLACE aims to promote the importance of these life-saving scans and encourage high-risk and hard-to-reach individuals, such as females and people living with comorbidities, to consider screening.



🌍 This   let’s keep in mind that early lung cancer diagnosis can save lives! The EU-funded SOLACE project is supporting ...
25/09/2024

🌍 This let’s keep in mind that early lung cancer diagnosis can save lives!

The EU-funded SOLACE project is supporting the roll out of lung cancer screening in the EU. Find out more and sign up for updates: https://lnkd.in/eukiSx7N

🕒Early diagnosis is key to fighting lung cancer. On World Patient Safety Day 2024, we want to highlight the importance o...
17/09/2024

🕒Early diagnosis is key to fighting lung cancer. On World Patient Safety Day 2024, we want to highlight the importance of strengthening lung cancer screening and protecting patients.

The SOLACE project is working to enhance awareness and participation rates in lung cancer screening, particularly in underrepresented communities. The project also aims to improve the quality of lung cancer screening across Europe.

https://europeanlung.org/solace/2024/06/05/solace-during-the-european-congress-of-radiology-ecr-2024/?utm_source=Europea...
02/09/2024

https://europeanlung.org/solace/2024/06/05/solace-during-the-european-congress-of-radiology-ecr-2024/?utm_source=European+Lung+Foundation&utm_campaign=73d96c2eb5-EMAIL_CAMPAIGN_2024_08_27_09_27&utm_medium=email&utm_term=0_-73d96c2eb5-%5BLIST_EMAIL_ID%5D

During the ECR 2024, the team of SOLACE project produced a series of short videos that explain the focus, the aims and the goals of the project. Each video, created by EIBIR, sheds light to different aspects of SOLACE and shows its impact.

10/11/2023
08/11/2023

[11/23 Mese del tumore al polmone]

🫁Nel tumore al polmone agire precocemente è fondamentale e può cambiare il percorso terapeutico dei pazienti aumentando così le opzioni di trattamento disponibili.

👨‍⚕️👩‍⚕️🧑‍⚕️Il Gruppo Interdisciplinare di Oncologia Toracica (GIOT) dell’Azienda Ospedaliero Universitaria di Parma, che si occupa della diagnosi e cura delle malattie neoplastiche polmonari con un approccio multidisciplinare, è altamente formato e organizzato per intervenire in fase precoce.

Vi presentiamo i professionisti che ne fanno parte, coordinati dal prof. Marcello Tiseo.

Nei prossimi post vi sveleremo chi sono e di cosa si occupano

05/08/2023

The leading medical society for radiology in Europe, we are dedicated to advancing the field through education, research, and innovation. Our annual European Congress of Radiology is the largest and…

Indirizzo

Via Gramsci 14
Parma
43100

Sito Web

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando PEOPLHE e RISP - Programmi di diagnosi precoce polmonare pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Digitare